Semaglutide and tirzepatide are prescription medications for chronic weight management to be used together with a reduced‑calorie diet and increased physical activity. Both are self‑administered, under‑the‑skin injectables prescribed to help patients lose excess weight when combined with lifestyle changes. Semaglutide is a GLP‑1 receptor agonist; tirzepatide is a dual GIP/GLP‑1 receptor agonist and may offer different effectiveness and side‑effect profiles. Treatment choice is individualized based on medical history, goals, and provider recommendation. Your first visit includes an initial assessment and your first‑month supply. Please call or text us for more information.